Skip to main content
Banana Farmer logo
Banana Farmer
System Transmission

_

Top Signal
100#1 JOB
Activity
2177Ripe
+933 today
System
Live1m
Terminal Asset View
stockNASDAQ

FTXH

$33.63-0.46%

FIRST TRUST NASDAQ PHARMACEUTICALS ETF

Overripe
Market value
24H Total Traded
Total supply
52-Week Range
Ripeness Index
Live Analysis Active

Company Mission

This ETF collects money from investors and uses it to buy a basket of pharmaceutical company stocks. It lets people invest in many drug makers at once instead of picking individual companies. The ETF makes money when the value of its stock holdings goes up or when those companies pay dividends.

FTX

Industry Context

The pharmaceutical industry develops and sells medicines and treatments. It's heavily regulated and faces challenges like drug patents expiring and new competition. This ETF gives investors exposure to many of these companies at once.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified
Asset Diagnostics

Technical Matrix

Scanning
54Matrix
Market Momentum
37.9Oversold / Recovery
Trend Strength
25Active Setup

Momentum Engine

Ready
44
Velocity Score
StaticOptimal FlowMax Vel
Trading Activity
0.3xNormal Volume
Today's Change
-0.46%Live Performance

Social Frequency

Listening
0
Social Freq
0.0x
Normal Vol
X/Twitter Activity
0.0xStreaming
Reddit Buzz
0.0xSynced
System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-1

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

© 2026 Precision Engine
0Velocity
Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing FTXH across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring
RedditMonitoring
WebMonitoring

Signal Catalysts

Intelligence Narrative Connected

Updated 07:26 PM UTC
As-of 03-14-2026 19:11 UTC
Invests in pharmaceutical companies that develop medicines and makes money from the fees charged to investors who buy its shares.
Price sits below key moving averages, suggesting a downtrend as sellers have dominated recent trading showing consolidation pattern.
Pharmaceutical sector faces patent cliffs and regulatory scrutiny, creating volatility that affects this Etf's holdings, suggesting Etf's holdings.

Educational only. Not investment advice.

Precision Intelligence Model
Live Terminal Stream

Loading chart...

Loading chart...

Loading chart...

Loading chart...